HomeCompareEXCOF vs MRK

EXCOF vs MRK: Dividend Comparison 2026

EXCOF yields 5.64% · MRK yields 3.25%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 EXCOF wins by $9.2K in total portfolio value
10 years
EXCOF
EXCOF
● Live price
5.64%
Share price
$5.43
Annual div
$0.31
5Y div CAGR
12.1%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$40.0K
Annual income
$3,293.70
Full EXCOF calculator →
MRK
Merck & Co. Inc.
● Live price
3.25%
Share price
$94.80
Annual div
$3.08
5Y div CAGR
8.2%
Payout ratio
42%
After 10 yrs · $10,000 · DRIP
Portfolio value
$30.7K
Annual income
$950.29
Full MRK calculator →

Portfolio growth — EXCOF vs MRK

📍 EXCOF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodEXCOFMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, EXCOF + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
EXCOF pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

EXCOF
Annual income on $10K today (after 15% tax)
$479.27/yr
After 10yr DRIP, annual income (after tax)
$2,799.65/yr
MRK
Annual income on $10K today (after 15% tax)
$276.16/yr
After 10yr DRIP, annual income (after tax)
$807.75/yr
At 15% tax rate, EXCOF beats the other by $1,991.90/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of EXCOF + MRK for your $10,000?

EXCOF: 50%MRK: 50%
100% MRK50/50100% EXCOF
Portfolio after 10yr
$35.4K
Annual income
$2,122.00/yr
Blended yield
6.00%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

EXCOF
No analyst data
Altman Z
3.2
Piotroski
8/9
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+35.6% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

EXCOF buys
0
MRK buys
0
No recent congressional trades found for EXCOF or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricEXCOFMRK
Forward yield5.64%3.25%
Annual dividend / share$0.31$3.08
Payout ratio50%42%
1-year div growth0%5.5%
5-year div CAGR12.1%8.2%
Portfolio after 10y$40.0K$30.7K
Annual income after 10y$3,293.70$950.29
Total dividends collected$16.2K$6.1K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: EXCOF vs MRK ($10,000, DRIP)

YearEXCOF PortfolioEXCOF Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$11,332$632.07$11,192$351.54+$140.00EXCOF
2$12,876$750.41$12,524$392.70+$352.00EXCOF
3$14,670$893.27$14,015$438.65+$655.00EXCOF
4$16,764$1,066.28$15,682$489.96+$1.1KEXCOF
5$19,213$1,276.50$17,547$547.23+$1.7KEXCOF
6$22,091$1,532.79$19,632$611.16+$2.5KEXCOF
7$25,484$1,846.37$21,963$682.53+$3.5KEXCOF
8$29,499$2,231.45$24,571$762.18+$4.9KEXCOF
9$34,270$2,706.17$27,486$851.08+$6.8KEXCOF
10$39,963$3,293.70$30,745$950.29+$9.2KEXCOF

EXCOF vs MRK: Complete Analysis 2026

EXCOFStock

Exco Technologies Limited, together with its subsidiaries, designs, develops, manufactures, and sells dies, molds, components and assemblies, and consumable equipment for the die-cast, extrusion, and automotive industries. It operates through two segments, Casting and Extrusion, and Automotive Solutions. The Casting and Extrusion segment designs, develops, and manufactures tooling and consumable parts for aluminum die-casting and aluminum extrusion machines. It has operations in North America, South America, Thailand, and Morocco; and serves automotive and industrial markets worldwide. The Automotive Solutions segment produces automotive interior trim components and assemblies primarily for passenger and light truck vehicles. This segment offers synthetic net and other cargo restraint products, injection-molded components, shift/brake boots, instrument panel components, sun visors, seat covers, head rests, other cut and sew products, and related interior trim components and assemblies. This segment also supplies plastic trunk trays and organizer systems, floor mats, and bumper covers, as well as die cut leather sets for seating applications. It has operations in Canada, the United States, Europe, Mexico, South America, Asia, and internationally. Exco Technologies Limited was founded in 1952 and is based in Markham, Canada.

Full EXCOF Calculator →

MRKHealthcare

Merck is a Dividend Aristocrat with 14+ consecutive years of increases. Keytruda (pembrolizumab) is the world's best-selling cancer drug and drives exceptional cash generation. The company's oncology and vaccines pipeline provides long-term growth visibility beyond the Keytruda patent cliff in the 2030s.

Full MRK Calculator →
📬

Get this EXCOF vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

EXCOF vs SCHDEXCOF vs JEPIEXCOF vs OEXCOF vs KOEXCOF vs MAINEXCOF vs JNJEXCOF vs ABBVEXCOF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.